STAAR Surgical exec reports tax-withholding share disposition
STAAR Surgical’s Chief Development Officer Magda Michna reported a routine tax-related share disposition.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
STAAR Surgical’s Chief Development Officer Magda Michna reported a routine tax-related share disposition. On May 8, 2026, 1,680 shares of common stock were withheld at $26.69 per share to cover taxes on previously granted restricted stock units that vested on that date.
The RSUs were granted on May 8, 2023 and vested in three roughly equal annual installments through May 8, 2026. After the tax withholding, Michna directly owns 32,691 shares of STAAR Surgical common stock. The filing also corrects a prior typo in reported holdings, confirming the correct earlier total was 29,688 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 1,680 | $26.69 | $45K |
Footnotes (2)
- F1. Reflects restricted stock units (RSUs) granted to the Reporting Person on May 8, 2023. These RSUs vested as to 1/3 (4,682 shares) on May 8, 2024, 1/3 (4,682 shares) on May 8, 2025, and 1/3 (4,683 shares) on May 8, 2026. On May 8, 2026, 1,680 shares were withheld to satisfy taxes.
- F2. This amount includes the corrected number of owned securities that was misreported on the Form 4 filed on March 12, 2026 due to a typo (the correct number was 29,688 and not 29,668).
Key Figures
Key Terms
restricted stock units (RSUs) financial
tax-withholding disposition financial
Form 4 financial
Common Stock financial
restricted stock units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did STAAR Surgical (STAA) executive Magda Michna report in this Form 4?
Was the STAAR Surgical (STAA) Form 4 transaction an open-market sale?
What correction to prior STAAR Surgical (STAA) holdings is disclosed in this Form 4?
What is the vesting schedule of the STAAR Surgical (STAA) RSUs in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.